D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene

Molecular Psychiatry

Volumn 3, Issue 3, 1998, Pages 261-265

  Laruelle, M ^a,b,c   Gelernter, J ^a,b   Innis, R B ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c The New York Presbyterian Hospital   (United States)

Author keywords

D2 receptors; Dopamine; Gene; Schizophrenia; SPECT

Indexed keywords

BRAIN RECEPTOR; DOPAMINE 2 RECEPTOR; TRACER; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; TAQ POLYMERASE;

ADULT; ALCOHOLISM; ALLELE; ARTICLE; CAUDATE NUCLEUS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; FEMALE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR GENE; SCHIZOPHRENIA; SUBSTANCE ABUSE; BINDING COMPETITION; BRAIN LEVEL; GENETICS; METABOLISM; PHYSIOLOGY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BINDING, COMPETITIVE; BRAIN CHEMISTRY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; TAQ POLYMERASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031596430     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000343     Document Type: Article

References (29)

1. 2 receptor gene in alcoholism. JAMA 1990; 263: 2055-2059.
2. Parsian A, Todd RD, Devor EJ, O'Malley KL, Suarez, BK, Reich T et al. Alcoholism and alleles of the human D2 dopamine receptor locus. Studies of association and linkage. Arch Gen Psychiatry 1991; 48; 655-663.
3. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 1991; 266: 1793-1800.
4. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Ozkaragoz T et al. Genetic predisposition in alcoholism: association of the D2 dopamine receptor Taq1 RFLP with severe alcoholics. Alcohol 1993; 10: 59-67.
5. Blum K, Noble EP, Sheridan PJ, Finley O, Montgomery A, Ritchie T et al. Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol 1991; 8: 409-416.
6. O'Hara BF, Smith SS, Bird G, Persico AM, Suarez BK, Cutting GR et al. Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteers. Hum Hered 1993; 43: 209-218.
7. Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D et al. Genetic vulnerability to drug abuse. The D2 dopamine receptor TaqI B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry 1992; 49: 723-727.
8. Noble E, Blum K, Khalsa M, Rithchie T, Montgomery, Woods RC et al. Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 1993; 33: 271-285.
9. Persico AM, Bird G, Gabbay FH, Uhl GR. D2 dopamine receptor gene Taq1 A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biol Psych 1996; 40: 776-784.
10. Gelernter J, O'Malley S, Risch N, Kranzler HR, Krystal J, Merikangas K et al. No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. JAMA 1991; 266: 1801-1807.
11. 2 receptor gene and alcoholism. JAMA 1990; 264: 3156-3160.
12. Turner E, Ewing J, Shilling P et al. Lack of association between an RFLP near the D2 receptor gene and severe alcoholism. Biol Psychiatry 1992; 31: 285-290.
13. 2 receptor gene. Alcohol Clin Exp Res 1992; 4: 806-809.
14. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991; 48: 646-654.
15. Noble EP, Berman SM, Ozkaragoz TZ, Ritchie T. Prolonged P300 latency in children with the D2 dopamine receptor A1 allele. Am J Hum Genet 1994; 54: 658-668.
16. Berman SM, Noble EP. Reduced visnospatial performance in children with the D2 receptor A1 allele. Behav Genet 1995; 25: 45-58.
17. Noble EP, Gottschalk LA, Fallon JH, Ritchie TL, Wu JC. D-2 dopamine receptor polymorphism and brain regional glucose metabolism. Am J Med Genet 1997; 74: 162-166.
18. Gejman PV, Ram A, Gelernter J, Friedman E, Cao Q, Pickar D et al. No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. JAMA 1994; 271: 204-208.
19. Hange X, Grandy DK, Eubanks JH, vans GA, Civelli O, Litt M. Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. Genomics 1991; 10: 527-530.
20. 125I]IBZM: a potential CNS D-2 dopamine receptor imaging agent. Nucl Med Biol 1988; 15: 195-201.
21. Laruelle M, D'Souza CD, Baldwin RM, Abi-Dargham A, Kanes SJ, Fingado CL et al. Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology 1997; 17: 162-174.
22. 11C]raclopride in man. Synapse 1995; 20: 200-208.
23. Laruelle M, Abi-Dargham A, van Dyck CH, Rosenblatt W, Zea-Ponce Y, Zoghbi SS et al. SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 1995; 36; 1182-1190.
24. 1H]raclopride. Proc Natt Acad Sci 1989; 86: 6412-6416.
25. 2 receptors in human subjects with iodine-123-IBZM. J Nucl Med 1992; 33: 1964-1971.
26. Abi-Dargham A, Gandelman M, Zoghbi SS, Laruelle M, Baldwin RM, Randall P et al. Reproducibility of SPECT measurement of bonzodiazepine receptors in human brain with iodine-123-iomazenil. J Nucl Med 1995; 36; 167-175.
27. Grandy DK, Zhang Y, Civelli O. PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet 1995; 2: 2197.
28. Castiglione CM, Deinard AS, Speed WC, Sirugo G, Rosenbaum HC, Zhang Y et al. Evolution of haplotypes at the DRD2 locus. Am J Hum Genet 1995; 57; 1445-1456.
29. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, De Souza CD, Erdos J et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug free schizophrenic subjects. Proc Natl Acad Sci 1996; 93: 9235-9240.